Phillipe has a background in Market Access and Strategic Pricing, with a focus on rare diseases and advanced therapies. His experience includes the assessment of funding options for cell therapies in oncology, as well as the development of market access strategies for innovative therapies in the orphan space.
PhD in Neuroscience from the Ecole Polytechnique Fédérale de Lausanne (EPFL). Master in Neuroscience, Strasbourg University. Industrial Pharmacist, Strasbourg School of Pharmacy